Serum levels of fibrin-fibrinogen degradation products in the haemolytic-uraemic syndrome.
作者信息
Uttley W S
出版信息
Arch Dis Child. 1970 Aug;45(242):587-9. doi: 10.1136/adc.45.242.587.
Abstract
摘要
相似文献
1
Serum levels of fibrin-fibrinogen degradation products in the haemolytic-uraemic syndrome.溶血尿毒综合征中纤维蛋白 - 纤维蛋白原降解产物的血清水平
Arch Dis Child. 1970 Aug;45(242):587-9. doi: 10.1136/adc.45.242.587.
2
Observations on the mechanism of the haematological changes in the haemolytic uraemic syndrome of infancy.关于婴儿溶血尿毒综合征血液学变化机制的观察
Br J Haematol. 1972 Sep;23:Suppl:53-9. doi: 10.1111/j.1365-2141.1972.tb03504.x.
3
Heparin therapy in the haemolytic-uraemic syndrome.
Lancet. 1969 Jun 7;1(7606):1123-6. doi: 10.1016/s0140-6736(69)91644-4.
4
Coagulation studies in the haemolytic uraemic syndrome.溶血尿毒综合征的凝血研究。
Arch Dis Child. 1972 Apr;47(252):315. doi: 10.1136/adc.47.252.315-b.
5
Fibrinogen catabolism in microangiopathic haemolytic anaemia.微血管病性溶血性贫血中的纤维蛋白原分解代谢
Br J Haematol. 1968 Jun;14(6):617-25. doi: 10.1111/j.1365-2141.1968.tb00368.x.
6
Coagulation studies in haemolytic uraemic syndrome.溶血尿毒综合征的凝血研究。
Arch Dis Child. 1972 Oct;47(255):766-71. doi: 10.1136/adc.47.255.766.
7
Coagulation studies and streptokinase therapy in the haemolytic-uraemic syndrome.
Helv Paediatr Acta. 1972 Apr;21(1):45-54.
8
Haemolytic-uraemic syndrome and heparin therapy.
Lancet. 1969 Sep 27;2(7622):700. doi: 10.1016/s0140-6736(69)90416-4.
9
Haemolytic-uraemic syndrome.溶血性尿毒综合征
Lancet. 1968 Sep 28;2(7570):735-6. doi: 10.1016/s0140-6736(68)90777-0.
10
Serum and urine fibrinogen-fibrin-related antigen (F.R.-antigen) levels in renal disease.肾脏疾病中血清及尿液纤维蛋白原-纤维蛋白相关抗原（F.R.-抗原）水平
Br Med J. 1972 Oct 14;4(5832):82-5. doi: 10.1136/bmj.4.5832.82.
引用本文的文献
1
Coagulation studies in haemolytic uraemic syndrome.溶血尿毒综合征的凝血研究。
Arch Dis Child. 1972 Oct;47(255):766-71. doi: 10.1136/adc.47.255.766.
本文引用的文献
1
Fibrin degradation products in sera of normal subjects.正常受试者血清中的纤维蛋白降解产物
Br Med J. 1967 Dec 23;4(5581):718-20. doi: 10.1136/bmj.4.5581.718.
2
Intravascular coagulation in an infant with the hemolytic-uremic syndrome.一名患有溶血尿毒综合征婴儿的血管内凝血
Acta Paediatr Scand. 1967 Jul;56(4):436-41. doi: 10.1111/j.1651-2227.1967.tb15403.x.
3
Recognition and treatment of intravascular coagulation.血管内凝血的识别与治疗。
J Pediatr. 1969 Feb;74(2):163-76. doi: 10.1016/s0022-3476(69)80064-8.
4
Treatment of patients with microangiopathic haemolytic anaemia with heparin.
Br J Haematol. 1968 Dec;15(6):603-21. doi: 10.1111/j.1365-2141.1968.tb01582.x.
5
A microhemagglutination-inhibition assay for the quantitation of fibrinogen breakdown products.一种用于定量纤维蛋白原降解产物的微量血凝抑制试验。
J Lab Clin Med. 1968 Feb;71(2):333-7.
6
Fibrin-fibrinogen degradation products in sera of normal infants and children.正常婴幼儿血清中的纤维蛋白-纤维蛋白原降解产物
Arch Dis Child. 1969 Dec;44(238):761-4. doi: 10.1136/adc.44.238.761.
7
Heparin therapy in the haemolytic-uraemic syndrome.
Lancet. 1969 Jun 7;1(7606):1123-6. doi: 10.1016/s0140-6736(69)91644-4.
Zotero 插件